Post Market Clinical Follow-Up of Acetabular Titan-Augment Structan®

NCT02019433 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2017-01-26

No results posted yet for this study

Summary

Implant Survival as well as clinical and radiological Follow-Up of acetabular Titan-Augment Structan®

Conditions

  • Total Hip Arthroplasty Revision

Interventions

DEVICE

Structan®

Sponsors & Collaborators

  • Aesculap AG

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2014-09-30
Completion
2014-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02019433 on ClinicalTrials.gov